Vontobel Holding
MRNA icon

Vontobel Holding’s Moderna MRNA Stock Holding History

Vontobel Holding’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$6.13M Sell
87,541
-75,881
-46% -$3.93M 0.02% 408
2026
Q1 		$8.3M Buy
163,422
+30,094
+23% +$1.4M 0.03% 284
2025
Q4 		$3.93M Sell
133,328
-88,476
-40% -$2.4M 0.01% 433
2025
Q3 		$5.73M Sell
221,804
-104,326
-32% -$2.91M 0.02% 358
2025
Q2 		$9M Buy
326,130
+64,424
+25% +$1.7M 0.03% 273
2025
Q1 		$7.42M Buy
261,706
+3,338
+1% +$118K 0.03% 261
2024
Q4 		$10.7M Buy
258,368
+142,280
+123% +$6.8M 0.04% 217
2024
Q3 		$7.76M Buy
116,088
+69,313
+148% +$6.36M 0.03% 254
2024
Q2 		$5.55M Buy
46,775
+15,902
+52% +$2.01M 0.02% 288
2024
Q1 		$3.29M Sell
30,873
-20,147
-39% -$2.03M 0.03% 375
2023
Q4 		$5.07M Buy
51,020
+3,904
+8% +$328K 0.04% 302
2023
Q3 		$4.87M Sell
47,116
-27,056
-36% -$3.02M 0.04% 293
2023
Q2 		$9.01M Buy
74,172
+16,735
+29% +$2.23M 0.08% 218
2023
Q1 		$8.82M Buy
57,437
+16,457
+40% +$2.71M 0.08% 218
2022
Q4 		$7.23M Sell
40,980
-110,536
-73% -$18.1M 0.07% 236
2022
Q3 		$17.9M Sell
151,516
-71,336
-32% -$10.8M 0.21% 116
2022
Q2 		$31.8M Buy
222,852
+109,467
+97% +$15.6M 0.34% 68
2022
Q1 		$19.8M Buy
113,385
+2,347
+2% +$395K 0.17% 128
2021
Q4 		$27.9M Sell
111,038
-15,915
-13% -$4.65M 0.23% 96
2021
Q3 		$48.9M Sell
126,953
-1,539
-1% -$568K 0.43% 45
2021
Q2 		$30.1M Buy
128,492
+69,751
+119% +$12.5M 0.26% 78
2021
Q1 		$7.69M Sell
58,741
-22,623
-28% -$3.28M 0.06% 191
2020
Q4 		$15.1M Buy
+81,364
New +$8.23M 0.1% 137

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Vontobel Holding's MRNA Position: Q2 2026 in Review

Vontobel Holding reduced its Moderna (MRNA) stake by 46% in Q2 2026, selling an estimated $3.93M and leaving 87,541 shares worth $6.13M. The position accounts for 0.02% of the portfolio, ranked #408.

Vontobel Holding first reported a position in MRNA in Q4 2020 and has held it in 23 quarters since. The position peaked at $48.9M in Q3 2021. 783 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Vontobel Holding held 87,541 shares of Moderna worth $6.13M as of Q2 2026.
  • Vontobel Holding sold 75,881 Moderna shares in Q2 2026, an estimated $3.93M.
  • Moderna made up 0.02% of Vontobel Holding's portfolio in Q2 2026, its #408 holding.
  • Vontobel Holding first reported a position in Moderna in Q4 2020 and has held it in 23 quarters since.
  • Vontobel Holding's Moderna position peaked at $48.9M in Q3 2021.
  • 783 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Vontobel Holding's 13F filing for Q2 2026, filed 3 Aug 2026.